Literature DB >> 10679285

De novo RNA synthesis catalyzed by HCV RNA-dependent RNA polymerase.

X L Sun1, R B Johnson, M A Hockman, Q M Wang.   

Abstract

The 65 kDa RNA-dependent RNA polymerase (NS5B), encoded by the hepatitis C virus (HCV) genome, is a key component involved in viral replication. Here we provide the direct evidence that purified HCV polymerase catalyzed de novo RNA synthesis in a primer-independent manner using homopolymers and HCV RNA as templates. The enzyme could utilize both polyC and polyU as templates for de novo RNA synthesis, suggesting that NS5B specifically recognized pyrimidine bases for initiation. More importantly, NS5B also catalyzed de novo RNA synthesis with an HCV RNA template; the resulting nascent RNA products, smaller than the template used, contained ATP as the first nucleotide. These results indicate that the newly synthesized RNAs did not result from template self-priming and suggest that a replication initiation site in the HCV RNA genome is a uridylate. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679285     DOI: 10.1006/bbrc.2000.2120

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Mechanism of de novo initiation by the hepatitis C virus RNA-dependent RNA polymerase: role of divalent metals.

Authors:  C T Ranjith-Kumar; Young-Chan Kim; Les Gutshall; Carol Silverman; Sanjay Khandekar; Robert T Sarisky; C Cheng Kao
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Template requirements for RNA synthesis by a recombinant hepatitis C virus RNA-dependent RNA polymerase.

Authors:  C C Kao; X Yang; A Kline; Q M Wang; D Barket; B A Heinz
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Resistance profile of a hepatitis C virus RNA-dependent RNA polymerase benzothiadiazine inhibitor.

Authors:  Tammy T Nguyen; Adam T Gates; Lester L Gutshall; Victor K Johnston; Baohua Gu; Kevin J Duffy; Robert T Sarisky
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

4.  Dinucleotide analogues as novel inhibitors of RNA-dependent RNA polymerase of hepatitis C Virus.

Authors:  Weidong Zhong; Haoyun An; Dinesh Barawkar; Zhi Hong
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

5.  Dissecting the requirement for subgenomic promoter sequences by RNA recombination of brome mosaic virus in vivo: evidence for functional separation of transcription and recombination.

Authors:  Rafal Wierzchoslawski; Aleksandra Dzianott; Jozef Bujarski
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  In vitro RNA replication directed by replicase complexes isolated from the subgenomic replicon cells of hepatitis C virus.

Authors:  Vicky C H Lai; Shannon Dempsey; Johnson Y N Lau; Zhi Hong; Weidong Zhong
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 7.  Hepatitis C Virus Replication.

Authors:  Keisuke Tabata; Christopher J Neufeldt; Ralf Bartenschlager
Journal:  Cold Spring Harb Perspect Med       Date:  2020-03-02       Impact factor: 6.915

8.  Mechanisms of activity and inhibition of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Stefan Reich; Ralph Peter Golbik; René Geissler; Hauke Lilie; Sven-Erik Behrens
Journal:  J Biol Chem       Date:  2010-03-01       Impact factor: 5.157

9.  Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase.

Authors:  W Zhong; E Ferrari; C A Lesburg; D Maag; S K Ghosh; C E Cameron; J Y Lau; Z Hong
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

10.  Selection of RNA aptamers that are specific and high-affinity ligands of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Antonino Biroccio; Jörg Hamm; Ilario Incitti; Raffaele De Francesco; Licia Tomei
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.